Navigation Links
Protalex, Inc. Announces Screening Of First Patients In U.S. For New Trial Of PRTX-100 In Patients With Active Rheumatoid Arthritis
Date:11/8/2012

eating autoimmune and inflammatory diseases, including but not limited to, rheumatoid arthritis. Protalex's lead product, PRTX-100, is formulated with a proprietary highly purified form of Staphylococcal Protein A, and has completed a Phase 1b clinical trial on adult patients with active rheumatoid arthritis in South Africa which demonstrated that PRTX-100 was generally safe and well tolerated at all dose level and at the higher doses, more patients showed improvement in their CDAI (Clinical Disease Activity Index for RA) than did patients at the lower dose or placebo cohorts. PRTX-100 has the ability, at very low concentrations, to bind to and to regulate activation of human B-lymphocytes and macrophages, which mediate inflammation in certain autoimmune diseases.  Laboratory studies indicate that the mechanism involves interaction with specific intracellular signaling pathways.

Forward-Looking Statements

Statements in this press release, including with respect to the outcome of the Phase 1b study described, that are not statements of historical or current fact constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the Company's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "believes," "belief," "expects," "expect," "intends," "intend," "anticipate," "anticipates," "plans," "plan," to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's filings with Securities and Exchange Commission.

Media Contact:
Mackenzie Mills
SpecO
'/>"/>

SOURCE Protalex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
2. ActiveCare Announces Record Revenue For Quarter Ending June 30, 2012
3. Echo Therapeutics Announces Third Quarter 2012 Financial Results
4. Concord Medical Announces Change to Third Quarter Financial Results Date to November 20, 2012
5. Winner Medical Announces Mailing of Definitive Proxy Materials for Special Meeting of Shareholders
6. Genoa Pharmaceuticals announces $1.2M Financing
7. Genomic Health Announces Third Quarter 2012 Financial Results and Business Progress
8. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
9. Life Technologies Announces Next-Gen Digital PCR Instrument Designed for Widespread Adoption
10. Blue Belt Technologies Announces First United Kingdom-Based NavioPFS Unicondylar Knee Replacement Surgery
11. IRIDEX Announces Tender Offer to Purchase up to 487,500 Shares of its Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... CHICAGO , July 31, 2015 ... Pipeline Review, 2015 market research report that provides ... pipeline stage using data sourced from in-house databases, ... on syringes and needles market products pipeline spread ... organizations supported with 73 tables and 5 figures ...
(Date:7/31/2015)... , July 31, 2015 Quietly, ... of experience, the domestic pharmaceutical industry is strong, with ... products to high international standards. One place ... is in sub-Saharan Africa: Morocco has quietly become the ... South Africa . Indeed, Moroccan pharma companies ...
(Date:7/31/2015)... CHICAGO , July 31, 2015 ... Composition Analyzers Market by Product (Bioimpedance Analyzers (BIA), Dual-Energy ... and Hydrostatic Weighing) - Global Analysis & Forecast to ... Market was pegged at $911.1 Million 2014 and is ... at a CAGR of 9.4% from 2014 to 2019. ...
Breaking Medicine Technology:Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4
... CV Therapeutics, Inc.,(Nasdaq: CVTX ) announced today ... Cardiology 57th Annual Scientific Session in Chicago,showed that ... isolated from animals and humans., The Company ... ranolazine may,contribute to the statistically significant reductions in ...
... PAREXEL International,Corporation (Nasdaq: PRXL ), a ... Company had completed the expansion of,three Clinical Pharmacology ... States; London, United Kingdom; and Berlin, Germany in ... in the early,phases of clinical development., "Continued ...
Cached Medicine Technology:New Data Shows Ranexa(R) Increases Glucose-Stimulated Insulin Secretion 2New Data Shows Ranexa(R) Increases Glucose-Stimulated Insulin Secretion 3PAREXEL Expands Global Clinical Pharmacology Capabilities 2PAREXEL Expands Global Clinical Pharmacology Capabilities 3PAREXEL Expands Global Clinical Pharmacology Capabilities 4PAREXEL Expands Global Clinical Pharmacology Capabilities 5
(Date:8/1/2015)... ... August 01, 2015 , ... BeverlyD, owner and founder of BeverlyD Luxe ... the very first small business donation to kick off the campaign for healing and ... Her legacy includes a complete line of raw, organic hair care products, as well ...
(Date:7/31/2015)... ... 2015 , ... Ticket Down is a reputable source of authentic tickets for the 2015 ... Fans of every genre of music will have an act they are excited to see ... festival, the following artists will perform: Sam Smith, Coldplay, Kenny Chesney, The Who, Jason ...
(Date:7/31/2015)... ... ... Ticket Down is a reliable source for authentic tickets for the 2015 ... festival will end on Sunday, August 2nd. , Music fans have traveled ... unique and unbelievably popular festival attracts the best in entertainment from around the world. ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... The 2nd ... Church Park in Downtown Memphis on October 3, 2015. The Ride to Fight On ... on cancer research between Methodist Healthcare, The West Clinic and The University of Tennessee ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... Insurance Group, Inc. has re-branded their social media profiles to better connect with ... for consumers to communicate, find information, share insights and opinions. The Rally Insurance ...
Breaking Medicine News(10 mins):Health News:March4thforWellBeing Foundation Kickoff 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2
... risk in teens, study suggests , TUESDAY, Dec. 15 ... increases the risk of obstructive sleep apnea, but the ... children, Australian researchers have found. , In sleep tests ... who were referred for evaluation of snoring and possible ...
... RPS Worldwide ... income... known as one of the simplest and easiest business opportunities in America today. ... Orlando, FL (PRWEB) December 15, ... cheer and good will that is going to stick around long after the season,s end. ...
... examines potential for injury when doctors decide benefits of ... News) -- MRI scans can pose a serious risk ... Food and Drug Administration researchers exposed pacemakers to a ... voltage produced at the tip of the pacemaker lead, ...
... nearly as accurate a surgical method, with fewer complications, ... When it comes to diagnosing breast cancer, women and ... that the less invasive "core needle biopsy" procedure is ... open surgical procedure is, with fewer complications than the ...
... , , NEW YORK, ... market research report is available in its catalogue: ... the U.S. and its International Trade [Q4 2009 ... newly published In-Vitro Diagnostic Substance Manufacturing Industry report ...
... ... R.I., Dec. 15 Mergers and acquisitions are commonplace today. As competitors ... they also must face integration challenges, including the integration of safety programs. ... Practices in a Hearing Conservation Program: US Airways ," details how the ...
Cached Medicine News:Health News:Puberty May Trigger Sleep Apnea in Overweight Kids 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 3Health News:Patients With Pacemakers Should Avoid MRI Scans 2Health News:Needle Biopsy Works Well in Diagnosing Breast Cancer 2Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 2Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 3Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 4
Urethral Red Rubber Catheters (Latex)...
Coude Foley Catheters (Latex) 2-Way Red...
Silicone Elastomer-Coated Latex Foley Catheters 3-Way...
Midstream Catch Kits...
Medicine Products: